Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.

@article{Niemann2011DifferencesIF,
  title={Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.},
  author={Markus Niemann and Sebastian Herrmann and Kai Hu and Frank B. Breunig and Joerg M. Strotmann and Meinrad Joachim Beer and Wolfram Machann and Wolfram V{\"o}lker and Georg Ertl and Christoph Wanner and Frank Weidemann},
  journal={JACC. Cardiovascular imaging},
  year={2011},
  volume={4 6},
  pages={592-601}
}
OBJECTIVES We hypothesized that Fabry cardiomyopathy in female patients might differ substantially from that in male patients and sought to prove this hypothesis in a large cohort consisting of 104 patients with Fabry disease. BACKGROUND Fabry cardiomyopathy in male patients is characterized by left ventricular (LV) hypertrophy, impaired myocardial function, and subsequent progressive myocardial fibrosis. In contrast, the occurrence of these 3 cardiomyopathic hallmarks in female patients… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 36 extracted citations

Echocardiographic assessment of fabry cardiomyopathy: early diagnosis and follow-up.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography • 2011
View 4 Excerpts
Highly Influenced

Neurometabolic Hereditary Diseases of Adults

Springer International Publishing • 2018

References

Publications referenced by this paper.
Showing 1-10 of 30 references

Long - term effects of enzyme replacement therapy on Fabry cardiomyopathy : evidence for a better outcome with early treatment

F Weidemann, F Breunig, M Beer
2009

Similar Papers

Loading similar papers…